NEW YORK, NY / ACCESSWIRE / December 8, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Priceline Group Inc. (NASDAQ: PCLN), bluebird bio (NASDAQ: BLUE), Cheniere Energy Inc. (NYSE: LNG) and Biogen Inc. (NASDAQ: BIIB). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
PCLN Research Package: http://www.traders-choice.com/pdf?s=PCLN
BLUE Research Package: http://www.traders-choice.com/pdf?s=BLUE
LNG Research Package: http://www.traders-choice.com/pdf?s=LNG
BIIB Research Package: http://www.traders-choice.com/pdf?s=BIIB
Highlights from today's reports include:
On Monday, December 7, 2015, the NASDAQ Composite ended at 5,101.81, down 0.79%, the Dow Jones Industrial Average edged 0.66% lower, to finish the day at 17,730.51, and the S&P 500 closed at 2,077.07, down 0.70%.
- The stock of Priceline Group Inc. gained 0.15% to close Monday's session at USD 1,302.42. The shares of the company moved in the range of USD 1,293.08 and USD 1,309.79. A trading volume of 0.41 million shares was recorded, which was lower than its 150-day daily average volume of 0.66 million shares. Over the last one week Priceline Group Inc.'s shares have advanced 4.29% but in the past one month the stock has lost 11.37%. Additionally, over the last three months the stock has advanced 4.59% and in the past six months the shares have registered a gain of 11.89%. The company has returned 14.68% in the past one year, on a compounded total return basis. Further, the company is trading at a price to earnings ratio of 26.98 and a price to book ratio of 7.65. This compares to a historical PE ratio of 24.96 and historical PB ratio of 6.91. Further, the stock is trading at a price to cash flow ratio of 21.52 and price to sales ratio of 7.14.
- bluebird bio Inc.'s stock decreased by 37.54% to close Monday's session at USD 52.25. The company's shares fluctuated in the range of USD 51.72 and USD 63.89. A total of 10.07 million shares exchanged hands, which surpassed its 50-day daily average volume of 1.79 million shares and its 52-week average volume of 1.07 million shares. Over the last three days bluebird bio Inc.'s shares have declined by 35.50% and in the past one week the stock has moved down 41.13%. However, the stock has returned 6.87% in last one year, on a compounded total return basis. Furthermore, over the last three months the stock has lost 59.60% and in the past six months the shares have shed 72.30%. Further, the stock is trading at a price to sales (TTM) ratio of 161.55 and a price to book (MRQ) ratio of 3.45. bluebird bio Inc. has market capitalization of USD 1.92 billion.
- Cheniere Energy Inc.'s stock slipped by 5.30% to close Monday's session at USD 42.16. The company's shares oscillated between USD 38.71 and USD 43.36 marking a new 52-week low during the session. The stock recorded a trading volume of 12.44 million shares, which was above its 50-day daily average volume of 3.32 million shares and above its 52-week average volume of 3.14 million shares. Over the last one week Cheniere Energy Inc.'s shares have declined by 11.34% and in the past one month the stock has lost 11.24%. In addition, over the last three months the stock has lost 24.85% and year to date the shares have shed 40.11%. Further, the stock is trading at a price to sales ratio of 39.15. Additionally, the stock is trading below its 50-day and 200-day moving averages of USD 47.03 and USD 59.03, respectively. Cheniere Energy Inc. has market capitalization of USD 9.95 billion.
- Biogen Inc.'s stock declined 0.99% to close Monday's session at USD 281.63. The share price vacillated between USD 279.70 and USD 284.98. The stock recorded a trading volume of 1.74 million shares, which was below its 50-day daily average volume of 2.80 million shares. Over the last three days Biogen Inc.'s shares have declined by 1.17% and in the past one week the stock has moved down 1.82%. Moreover, in the last six months the stock has lost 27.11% and year to date the shares have shed 17.03%. Further, the stock is trading at a price to earnings ratio of 18.40 and a price to book ratio of 6.00. This compares to a historical PE ratio of 27.43 and historical PB ratio of 7.37. Additionally, the stock is trading at a price to cash flow ratio of 15.00 and price to sales ratio of 6.00. Biogen Inc. has market capitalization of USD 62.78 billion.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice